{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-113809","form_type":"8-K","ticker":"WW","cik":"0000105319","company_name":"WW INTERNATIONAL, INC.","filed_at":"2025-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.332703+00:00","generated_at":"2026-05-22T10:36:53.403446+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"WW Q1 revenue down 9.7% to $186.6M; clinical revenue up 57%; in debt restructuring talks","bullets":["Net loss improved to $72.6M ($0.91 EPS loss) from $347.9M ($4.39) YoY.","Clinical subscription revenue rose 57.1% to $29.5M; total subscribers fell 14.2% to 3.4M.","Adjusted EBITDAS surged to $26.9M from $7.2M; gross margin expanded 450 bps to 71.2%.","Substantive discussions with lenders/noteholders on debt-reduction plan expected imminently.","Cash and equivalents $236.3M including $171.3M drawn on revolver."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-113809","json":"https://secwatch.observer/filing/0001193125-25-113809.json","markdown":"https://secwatch.observer/filing/0001193125-25-113809.md","text":"https://secwatch.observer/filing/0001193125-25-113809.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/105319/000119312525113809/0001193125-25-113809-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105319/000119312525113809/d895450d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T10:36:53.403446+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}